Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics
| Image |  |
|---|---|
| Description | scientific article published on 07 January 2016 |
| Author/s | |
| Publication date | January 7, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |